Patrick Thomas Ellinor II - 06 Aug 2026 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Reporting relationship: Director
Issuer ticker: EDIT
Reported as of: 06 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Aug 2026, 17:16:31 UTC
Source filing: View source filing
Reporting owner signature: /s/ Patrick Ellinor

Key filing fact

Patrick Thomas Ellinor II filed Form 4 for Editas Medicine, Inc. (EDIT) on 07 Aug 2026.

Key facts

This page summarizes Patrick Thomas Ellinor II's Form 4 filing for Editas Medicine, Inc. (EDIT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Aug 2026, 17:16.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002137699 Primary reporting owner

Ellinor Patrick Thomas II

Relationship: Director
Address: 11 HURLEY STREET, CAMBRIDGE
Signature: /s/ Patrick Ellinor
Signature date: 07 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EDIT transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +103,400
Change %
Price: $0.000000^*
Shares after: 103,400
Date: 06 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 103,400
Exercise price: $2.90
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option was granted on August 6, 2026 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on August 6, 2027 through August 6, 2029.